Published :
Tables : 160
Figures : 35
Category : Healthcare
No. of Pages : 200
Report Code : HC-1266
Medical Aesthetics Market Introduction: Medical Aesthetics Market is estimated to value over USD 18.5 billion by 2027 end and register a CAGR of over 10% during the forecast period 2020 to 2027. Medical aesthetic devices are used for treating a person’s impairments related to aesthetic appearances like unwanted hair, cellulite, scars, spider veins, excessive fat, skin discoloration, moles, skin laxity, wrinkles and liver spots. Aesthetic medicines include both non-surgical and surgical procedures and physicians may choose a combination of both to intensify the patient’s physical appearance. Convenient replacement of missing or dysfunctional body parts caused by trauma, accidents and other congenital disorders is possible by the usage of medical aesthetic implants. Technological advancements, increase in demand for non-invasive or minimally invasive reconstruction surgical operations, increase in trauma cases and road accidents, high incidence of breast cancer, rise in number of cosmetology surgeons, high prevalence of congenital face and tooth deformities and increase in the number of awareness programs like breast reconstructive awareness campaign, which was initiated in the United States, steer the medical aesthetic devices market growth. Although, low reimbursements, high treatment costs, and risk of implant-associated malfunctions are primary factors that restrain this market growth. Rise in popularity of celebrities amongst the young population who encourage them to look aesthetically appealing, increase in preference for a better quality of life, growing medical tourism and are expected to provide numerous lucrative opportunities for market players which shall expand the medical aesthetics market size. Key players included in the global medical aesthetics market industry are Allergan, Alma Lasers Ltd., Anika Therapeutics Inc., Cutera Inc., Cynosure, El.En S.P.A, Fotona D.O.O, Galderma, Johnson & Johnson, Merz Aesthetics Inc., Medytox Inc., Sientra Inc., Sinclair Pharma PLC, Solta Medical, Syneron Medical Ltd. Medical Aesthetics Market Segmentation: By Product Facial Aesthetic Products Botulinum Toxin Dermal Filters Natural Dermal Filters Synthetic Dermal Filters Chemical Peels Microdermabrasion Devices Body Contouring Devices Non-Surgical Fat Reduction Devices Cellulite Reduction Devices Liposuction Devices Cosmetic Implants Breast Implants Silicone Breast Implants Saline Breast Implants Facial Implants Other Cosmetic Implants Physician-Dispensed Cosmeceuticals and Skin Lighteners Skin Aesthetic Devices Laser Skin Resurfacing Devices Non-Surgical Skin Tightening Devices Micro-Needling Products Light Therapy Devices Physician-Dispensed Eyelash Products Hair Removal Devices Laser Hair Removal Devices IPL Hair Removal Devices Tattoo Removal Devices Thread Lift Products Nail Treatment Laser Devices By End User Clinics, Hospitals and Medical S.P.A. s Beauty Centres Home Care Settings By Region North America Europe Asia Pacific Latin America Middle East & Africa FutureWise Key Takeaways: Growth prospects SWOT analysis Key trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global medical aesthetics market by product, by end user and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East & Africa To record evaluate and competitive landscape mapping- product launches, technological advancements, mergers and expansions Profiling of companies to evaluate their market shares, strategies, financials and core competencies Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Medical Aesthetics Market is estimated to value over USD 18.5 billion by 2027 end and register a CAGR of over 10% during the forecast period 2020 to 2027.
Medical aesthetic devices are used for treating a person’s impairments related to aesthetic appearances like unwanted hair, cellulite, scars, spider veins, excessive fat, skin discoloration, moles, skin laxity, wrinkles and liver spots. Aesthetic medicines include both non-surgical and surgical procedures and physicians may choose a combination of both to intensify the patient’s physical appearance. Convenient replacement of missing or dysfunctional body parts caused by trauma, accidents and other congenital disorders is possible by the usage of medical aesthetic implants.
Technological advancements, increase in demand for non-invasive or minimally invasive reconstruction surgical operations, increase in trauma cases and road accidents, high incidence of breast cancer, rise in number of cosmetology surgeons, high prevalence of congenital face and tooth deformities and increase in the number of awareness programs like breast reconstructive awareness campaign, which was initiated in the United States, steer the medical aesthetic devices market growth. Although, low reimbursements, high treatment costs, and risk of implant-associated malfunctions are primary factors that restrain this market growth. Rise in popularity of celebrities amongst the young population who encourage them to look aesthetically appealing, increase in preference for a better quality of life, growing medical tourism and are expected to provide numerous lucrative opportunities for market players which shall expand the medical aesthetics market size.
Key players included in the global medical aesthetics market industry are Allergan, Alma Lasers Ltd., Anika Therapeutics Inc., Cutera Inc., Cynosure, El.En S.P.A, Fotona D.O.O, Galderma, Johnson & Johnson, Merz Aesthetics Inc., Medytox Inc., Sientra Inc., Sinclair Pharma PLC, Solta Medical, Syneron Medical Ltd.
Medical Aesthetics Market Segmentation:
By Product
By End User
By Region
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data From Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data From Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Medical Aesthetics Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards And Compliances 5. Global Medical Aesthetics Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Medical Aesthetics Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Medical Aesthetics Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global Medical Aesthetics Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. Facial Aesthetic Products 7.1.1. Botulinum Toxin 7.1.2. Dermal Filters 7.1.2.1. Natural Dermal Filters 7.1.2.2. Synthetic Dermal Filters 7.1.3. Chemical Peels 7.1.4. Microdermabrasion Devices 7.2. Body Contouring Devices 7.2.1. Non-Surgical Fat Reduction Devices 7.2.2. Cellulite Reduction Devices 7.2.3. Liposuction Devices 7.3. Cosmetic Implants 7.3.1. Breast Implants 7.3.1.1. Silicone Breast Implants 7.3.1.2. Saline Breast Implants 7.3.2. Facial Implants 7.3.3. Other Cosmetic Implants 7.4. Physician-Dispensed Cosmeceuticals and Skin Lighteners 7.5. Skin Aesthetic Devices 7.5.1. Laser Skin Resurfacing Devices 7.5.2. Non-Surgical Skin Tightening Devices 7.5.3. Micro-Needling Products 7.5.4. Light Therapy 7.6. Physician-Dispensed Eyelash Products 7.7. Hair Removal Devices 7.7.1. Laser hair Removal Devices 7.7.2. IPL Hair Removal Devices 7.8. Tattoo Removal Devices 7.9. Thread Lift Products 7.9. Nail Treatment Laser Devices 8. Global Medical Aesthetics Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Clinics, Hospitals and Medical S.P.A. s 8.2. Beauty Centers 8.3. Home Care Settings 9. North America Medical Aesthetics Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 9.1. Introduction 9.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 9.2.1. U.S.A 9.2.2. Canada 9.3. Market Size (USD Million) Forecast for North America 2020-2027 10. Latin America Medical Aesthetics Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 10.2.1. Brazil 10.2.2. Mexico 10.2.3. Rest of Latin America 10.3. Market Size (USD Million) Forecast for Latin America 2020-2027 11. Europe Medical Aesthetics Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 11.2.1. Germany 11.2.2. U.K 11.2.3. France 11.2.4. Italy 11.2.5. Spain 11.2.6. Russia 11.2.7. Poland 11.2.8. Rest of Europe 11.3. Market Size (USD Million) Forecast for Europe 2020-2027 12. Asia Pacific Medical Aesthetics Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019 12.2.1. Japan 12.2.2. China 12.2.3. India 12.2.4. Australia and New Zealand 12.2.5. ASEAN 12.2.6. Rest of Asia Pacific 12.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 13. Middle East and Africa Medical Aesthetics Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Saudi Arabia 13.2.2. UAE 13.2.3. South Africa 13.2.4. Egypt 13.3. Market Size (USD Million) Forecast for MEA 2020-2027 14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 14.1. Allergan 14.1.1. Company Overview 14.1.2. Product Portfolio 14.1.3. SWOT Analysis 14.1.4. Financial Overview 14.1.5. Strategic Overview 14.2. Alma Lasers Ltd. 14.2.1. Company Overview 14.2.2. Product Portfolio 14.2.3. SWOT Analysis 14.2.4. Financial Overview 14.2.5. Strategic Overview 14.3. Anika Therapeutics Inc. 14.3.1. Company Overview 14.3.2. Product Portfolio 14.3.3. SWOT Analysis 14.3.4. Financial Overview 14.3.5. Strategic Overview 14.4. Cutera Inc. 14.4.1. Company Overview 14.4.2. Product Portfolio 14.4.3. SWOT Analysis 14.4.4. Financial Overview 14.4.5. Strategic Overview 14.5 Cynosure 14.5.1. Company Overview 14.5.2. Product Portfolio 14.5.3. SWOT Analysis 14.5.4. Financial Overview 14.5.5. Strategic Overview 14.6. El.En S.P.A 14.6.1. Company Overview 14.6.2. Product Portfolio 14.6.3. SWOT Analysis 14.6.4. Financial Overview 14.6.5. Strategic Overview 14.7. Fotona D.O.O 14.7.1. Company Overview 14.7.2. Product Portfolio 14.7.3. SWOT Analysis 14.7.4. Financial Overview 14.7.5. Strategic Overview 14.8. Galderma 14.8.1. Company Overview 14.8.2. Product Portfolio 14.8.3. SWOT Analysis 14.8.4. Financial Overview 14.8.5. Strategic Overview 14.9. Johnson & Johnson 14.9.1. Company Overview 14.9.2. Product Portfolio 14.9.3. SWOT Analysis 14.9.4. Financial Overview 14.9.5. Strategic Overview 14.10. Merz Aesthetics Inc. 14.10.1. Company Overview 14.10.2. Product Portfolio 14.10.3. SWOT Analysis 14.10.4. Financial Overview 14.10.5. Strategic Overview 14.11. Medytox Inc. 14.11.1. Company Overview 14.11.2. Product Portfolio 14.11.3. SWOT Analysis 14.11.4. Financial Overview 14.11.5. Strategic Overview 14.12. Sientra Inc. 14.12.1. Company Overview 14.12.2. Product Portfolio 14.12.3. SWOT Analysis 14.12.4. Financial Overview 14.12.5. Strategic Overview 14.13. Sinclair Pharma PLC 14.13.1. Company Overview 14.13.2. Product Portfolio 14.13.3. SWOT Analysis 14.13.4. Financial Overview 14.13.5. Strategic Overview 14.14. Solta Medical 14.14.1. Company Overview 14.14.2. Product Portfolio 14.14.3. SWOT Analysis 14.14.4. Financial Overview 14.14.5. Strategic Overview 14.15 Syneron Medical Ltd. 14.15.1. Company Overview 14.15.2. Product Portfolio 14.15.3. SWOT Analysis 14.15.4. Financial Overview 14.15.5. Strategic Overview 15. Impact of COVID-19 15.1. Positive influence on the healthcare industry 15.2. The financial disruption of the manufacturing sector 15.3. Impact of COVID-19 on emerging companies 15.4. Significant mandates in the healthcare regulations initiated by administrations 15.5. The overall economic slowdown of the developing and developed nations 16. FutureWise SME Key Takeaway Points for Client
1. Market Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Years Considered for the Study
1.3.2 Market Covered
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2. Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study
3. Executive Summary
3.1 Market Outlook
3.2 Segment Outlook
3.3 Competitive Insights
4. Global Medical Aesthetics Market Variables, Trends & Scope
4.1. Market Lineage Outlook
4.2. Penetration and Growth Prospect Mapping
4.3. Industry Value Chain Analysis
4.4. Cost Analysis Breakdown
4.5. Technology Overview
4.6. Regulatory Framework
4.6.1. Reimbursement Framework
4.6.2. Standards And Compliances
5. Global Medical Aesthetics Market Overview
5.1. Market Dynamics
5.1.1. Market Driver Analysis
5.1.1.1. Increasing focus of Medical Aesthetics Companies on Brand Protection
5.1.1.2. Untapped Opportunities in Emerging Regions
5.1.2. Market Restraint Analysis
5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
5.1.3. Industry Challenges
5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Medical Aesthetics Market Analysis Tools
6.1. Industry Analysis - Porter’s
6.1.1. Supplier Power
6.1.2. Buyer Power
6.1.3. Substitution Threat
6.1.4. Threat from New Entrants
6.1.5. Competitive Rivalry
6.2. Pestel Analysis
6.2.1. Political Landscape
6.2.2. Environmental Landscape
6.2.3. Social Landscape
6.2.4. Technology Landscape
6.2.5. Legal Landscape
6.3. Major Deals And Strategic Alliances Analysis
6.3.1. Joint Ventures
6.3.2. Mergers and Acquisitions
6.3.3. Licensing and Partnership
6.3.4. Technology Collaborations
6.3.5. Strategic Divestments
6.4. Market Entry Strategies
6.5. Case Studies
7. Global Medical Aesthetics Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million)
7.1. Facial Aesthetic Products
7.1.1. Botulinum Toxin
7.1.2. Dermal Filters
7.1.2.1. Natural Dermal Filters
7.1.2.2. Synthetic Dermal Filters
7.1.3. Chemical Peels
7.1.4. Microdermabrasion Devices
7.2. Body Contouring Devices
7.2.1. Non-Surgical Fat Reduction Devices
7.2.2. Cellulite Reduction Devices
7.2.3. Liposuction Devices
7.3. Cosmetic Implants
7.3.1. Breast Implants
7.3.1.1. Silicone Breast Implants
7.3.1.2. Saline Breast Implants
7.3.2. Facial Implants
7.3.3. Other Cosmetic Implants
7.4. Physician-Dispensed Cosmeceuticals and Skin Lighteners
7.5. Skin Aesthetic Devices
7.5.1. Laser Skin Resurfacing Devices
7.5.2. Non-Surgical Skin Tightening Devices
7.5.3. Micro-Needling Products
7.5.4. Light Therapy
7.6. Physician-Dispensed Eyelash Products
7.7. Hair Removal Devices
7.7.1. Laser hair Removal Devices
7.7.2. IPL Hair Removal Devices
7.8. Tattoo Removal Devices
7.9. Thread Lift Products
7.9. Nail Treatment Laser Devices
8. Global Medical Aesthetics Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
8.1. Clinics, Hospitals and Medical S.P.A. s
8.2. Beauty Centers
8.3. Home Care Settings
9. North America Medical Aesthetics Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million)
9.1. Introduction
9.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019
9.2.1. U.S.A
9.2.2. Canada
9.3. Market Size (USD Million) Forecast for North America 2020-2027
10. Latin America Medical Aesthetics Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million)
10.1. Introduction
10.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Market Size (USD Million) Forecast for Latin America 2020-2027
11. Europe Medical Aesthetics Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million)
11.1. Introduction
11.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019
11.2.1. Germany
11.2.2. U.K
11.2.3. France
11.2.4. Italy
11.2.5. Spain
11.2.6. Russia
11.2.7. Poland
11.2.8. Rest of Europe
11.3. Market Size (USD Million) Forecast for Europe 2020-2027
12. Asia Pacific Medical Aesthetics Market Analysis 2012–2019 and Forecast 2020–2027 (USD Million)
12.1. Introduction
12.2. Historical Market Size (USD Million) Analysis By Country, 2012-2019
12.2.1. Japan
12.2.2. China
12.2.3. India
12.2.4. Australia and New Zealand
12.2.5. ASEAN
12.2.6. Rest of Asia Pacific
12.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
13. Middle East and Africa Medical Aesthetics Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
13.1. Introduction
13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
13.2.1. Saudi Arabia
13.2.2. UAE
13.2.3. South Africa
13.2.4. Egypt
13.3. Market Size (USD Million) Forecast for MEA 2020-2027
14. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
14.1. Allergan
14.1.1. Company Overview
14.1.2. Product Portfolio
14.1.3. SWOT Analysis
14.1.4. Financial Overview
14.1.5. Strategic Overview
14.2. Alma Lasers Ltd.
14.2.1. Company Overview
14.2.2. Product Portfolio
14.2.3. SWOT Analysis
14.2.4. Financial Overview
14.2.5. Strategic Overview
14.3. Anika Therapeutics Inc.
14.3.1. Company Overview
14.3.2. Product Portfolio
14.3.3. SWOT Analysis
14.3.4. Financial Overview
14.3.5. Strategic Overview
14.4. Cutera Inc.
14.4.1. Company Overview
14.4.2. Product Portfolio
14.4.3. SWOT Analysis
14.4.4. Financial Overview
14.4.5. Strategic Overview
14.5 Cynosure
14.5.1. Company Overview
14.5.2. Product Portfolio
14.5.3. SWOT Analysis
14.5.4. Financial Overview
14.5.5. Strategic Overview
14.6. El.En S.P.A
14.6.1. Company Overview
14.6.2. Product Portfolio
14.6.3. SWOT Analysis
14.6.4. Financial Overview
14.6.5. Strategic Overview
14.7. Fotona D.O.O
14.7.1. Company Overview
14.7.2. Product Portfolio
14.7.3. SWOT Analysis
14.7.4. Financial Overview
14.7.5. Strategic Overview
14.8. Galderma
14.8.1. Company Overview
14.8.2. Product Portfolio
14.8.3. SWOT Analysis
14.8.4. Financial Overview
14.8.5. Strategic Overview
14.9. Johnson & Johnson
14.9.1. Company Overview
14.9.2. Product Portfolio
14.9.3. SWOT Analysis
14.9.4. Financial Overview
14.9.5. Strategic Overview
14.10. Merz Aesthetics Inc.
14.10.1. Company Overview
14.10.2. Product Portfolio
14.10.3. SWOT Analysis
14.10.4. Financial Overview
14.10.5. Strategic Overview
14.11. Medytox Inc.
14.11.1. Company Overview
14.11.2. Product Portfolio
14.11.3. SWOT Analysis
14.11.4. Financial Overview
14.11.5. Strategic Overview
14.12. Sientra Inc.
14.12.1. Company Overview
14.12.2. Product Portfolio
14.12.3. SWOT Analysis
14.12.4. Financial Overview
14.12.5. Strategic Overview
14.13. Sinclair Pharma PLC
14.13.1. Company Overview
14.13.2. Product Portfolio
14.13.3. SWOT Analysis
14.13.4. Financial Overview
14.13.5. Strategic Overview
14.14. Solta Medical
14.14.1. Company Overview
14.14.2. Product Portfolio
14.14.3. SWOT Analysis
14.14.4. Financial Overview
14.14.5. Strategic Overview
14.15 Syneron Medical Ltd.
14.15.1. Company Overview
14.15.2. Product Portfolio
14.15.3. SWOT Analysis
14.15.4. Financial Overview
14.15.5. Strategic Overview
15. Impact of COVID-19
15.1. Positive influence on the healthcare industry
15.2. The financial disruption of the manufacturing sector
15.3. Impact of COVID-19 on emerging companies
15.4. Significant mandates in the healthcare regulations initiated by administrations
15.5. The overall economic slowdown of the developing and developed nations
16. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics